Merck KGaA (NASDAQ:MKGAY) was upgraded by equities research analysts at Bank of America Corp. from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday.

Several other analysts also recently issued reports on the company. Berenberg Bank downgraded Merck KGaA from a “buy” rating to a “hold” rating in a report on Friday, August 12th. Credit Suisse Group AG raised Merck KGaA from a “neutral” rating to an “outperform” rating and set a $73.00 price target on the stock in a report on Wednesday, August 10th. Jefferies Group reissued a “hold” rating and issued a $57.00 price target (up previously from $53.00) on shares of Merck KGaA in a report on Wednesday, August 10th. Finally, BMO Capital Markets reissued a “market perform” rating on shares of Merck KGaA in a report on Monday, July 18th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Merck KGaA has an average rating of “Hold” and a consensus price target of $65.00.

Shares of Merck KGaA (NASDAQ:MKGAY) opened at 35.23 on Friday. Merck KGaA has a 52-week low of $26.91 and a 52-week high of $37.16. The stock has a market capitalization of $46.00 billion and a P/E ratio of 29.72. The firm’s 50-day moving average price is $35.69 and its 200-day moving average price is $33.57.

5 Day Chart for NASDAQ:MKGAY

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.